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Abstract
Background: Macrophage-derived lipoprotein lipase (LPL) has been shown uniformly to promote atherosclerotic lesion
formation while the extent to which it affects plasma lipid and lipoprotein levels varies in wild-type and
hypercholesterolemic mice. It is known that high levels of LPL in the bulk of adipose tissue and skeletal muscle would
certainly mask the contribution of macrophage LPL to metabolism of plasma lipoprotein. Therefore, we chose LPL deficient
(LPL
-/-) mice with severe hypertriglyceridemia as an alternative model to assess the role of macrophage LPL in plasma
lipoprotein metabolism via bone marrow transplant, through which LPL will be produced mainly by hematopoietic cell-
derived macrophages.
Methods and Results: Hypertriglyceridemic LPL
-/- mice were lethally irradiated, then transplanted with bone marrow from
wild-type (LPL
+/+) or LPL
-/- mice, respectively. Sixteen weeks later, LPL
+/+ RLPL
-/- mice displayed significant reduction in
plasma levels of triglyceride and cholesterol (408644.9 vs. 2.760.5610
3 and 82.967.1 vs. 229.1630.6 mg/dl, p,0.05,
respectively), while a 2.7-fold increase in plasma high density lipoprotein- cholesterol (p,0.01) was observed, compared
with LPL
-/-RLPL
-/- control mice. The clearance rate for the oral fat load test in LPL
+/+ RLPL
-/- mice was faster than that in
LPL
-/-RLPL
-/- mice, but slower than that in wild-type mice. Liver triglyceride content in LPL
+/+RLPL
-/- mice was also
significantly increased, compared with LPL
-/-RLPL
-/- mice (6.860.7 vs. 4.660.5 mg/g wet tissue, p,0.05, n=6). However, no
significant change was observed in the expression levels of genes involved in hepatic lipid metabolism between the two
groups.
Conclusions: Hematopoietic cell-derived LPL could efficiently ameliorate severe hypertriglyceridemia and hypo-alpha-
cholesterolemia at the compensation of increased triglyceride content of liver in LPL
-/- mice.
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Introduction
Lipoprotein lipase (LPL) is the rate-limiting enzyme responsible
for hydrolysis of circulating triglycerides (TGs) carried in very low
density lipoprotein (VLDL) and chylomicron (CM). Generally,
LPL is produced primarily by muscle and adipose cells. However,
a small amount of LPL is also detectable in differentiated
macrophages and macrophage- derived foam cells in atheroscle-
rotic lesions [1,2].
It is well documented that LPL plays a central role in the
metabolism of TG-rich lipoproteins (TRLs). Total LPL deficiency
in humans (type I hyperlipoproteinemia) is associated with severe
hypertriglyceridemia and hypo-alpha-cholesterolemia. Moreover,
the major role of muscle LPL in the regulation of plasma TG levels
has been determined by studies done in transgenic mice expressing
LPL exclusively in skeletal or cardiac muscle [3,4]. Despite
mounting evidence consistently suggesting the proatherosclerotic
function of macrophage LPL in atherosclerotic lesion formation in
vivo [5,6,7], the relative contribution of macrophage LPL to
lipoprotein metabolism remains unclear. Through the introduc-
tion of LPL gene deleted macrophages by fetal liver cell
transplantation into wild-type C57BL/6 or LDL receptor-deficient
mice, Babaev et al demonstrated that macrophage LPL deficiency
had no effect on serum lipid levels[8,9]. In contrast, Van Eck et al
observed that transplantation of LPL-deficient hematopoietic stem
cells into lethally irradiated LPL
+/+ mice did exert a mild but
significant impact on plasma lipids levels with 30% elevation in
TG while 8% reduction in total cholesterol (TC) when the animals
were fed on normal chow diet. On high fat diet no difference in
TG was found between the two bone marrow transplantation
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e25620(BMT) groups whereas reduction in TC in macrophage-specific
LPL deleted mice became more prominent [10]. These studies
thus far have provided a valuable but unresolved picture of
macrophage LPL in lipoprotein metabolism.
It is obvious that the effects of macrophage LPL on the plasma
lipids and lipoproteins would be easily masked by large amounts of
LPL synthesized in adipose tissue and skeletal muscle mass. For
this reason, the distinct physiological role of macrophage LPL in
lipoprotein metabolism might only be properly assessable under
conditions in which LPL activity is limiting, such as in LPL
-/-
recipient mice, as suggested by Van Eck and Babaev et al[8,9,10].
However, homozygous LPL knock-out mice die shortly after birth,
making it difficult to discern the effects of macrophage LPL from
that of the whole-body LPL pool in a well-controlled animal model
system[11].
In previous studies, we have reported that gene transfer of the
human LPL S447X variant successfully rescued LPL-deficient
mice to adulthood [12]. With this specific hypertriglyceridemic
(HTG) model, we have determined the effects of LPL deficiency
on atherosclerosis development, pancreatitis susceptibility and
cognitive function [13,14,15]. Recently, Nordestgaard BG et al
reported that elevated nonfasting TG levels were associated with
increased risk of myocardial infarction, ischemic heart disease and
death in men and women [16]. Moreover, hypertriglyceridemia
has been increasingly recognized as an independent risk factor in
the pathogenesis of atherosclerosis [13,17,18]. Therefore, it is of
particular interest to investigate whether LPL from macrophages
plays any role in the LPL deficient severe HTG state, which may
provide new insight on the effects of macrophage LPL on
lipoprotein metabolism other than atherosclerosis.
In the current study, bone marrow from wild-type (LPL
+/+)o r
LPL deficient (LPL
-/-) mice was transplanted into irradiated
LPL
-/- mice as an alternative model, in which LPL will be
produced mainly from hematopoietic cell-derived macrophages. It
was interesting to note that hematopoietic cell-derived LPL alone
was nearly sufficient to normalize the lipoprotein metabolism at
the compensation of increased TG content of liver in LPL
-/- mice.
Moreover, these results provided direct evidence that LPL derived
from hematopoietic cell also performs a crucial role in clearance of
TRLs in the setting of severe hypertriglyceridemia.
Results
Plasma lipid and lipoproteins
All mice were fed a normal chow diet and fasted plasma. TG,
TC and HDL cholesterol (HDL-C) levels were measured at the
time of BMT up to 16 weeks. As early as 4 weeks after BMT,
plasma TG and TC levels in LPL
+/+RLPL
-/- mice were rapidly
reduced by 59.4% (699.66105.1 vs. 1.760.2610
3 mg/dl,
p,0.05) and 46.3% (82.4617.4 vs. 153.5616 mg/dl, p,0.05),
while an almost 3-fold increase in plasma HDL-C (29.165.4 vs.
11.860.5 mg/dl, p,0.01) was observed, compared with
LPL
-/-RLPL
-/- control mice (figure 1A,1B,1C). The disparity
between the two groups was further enlarged at the time of 8 and
16 weeks after BMT.
The lipoprotein profiles are shown in figures 2A and 2B, as
expressed either in TG or cholesterol (Chol.) contents in each
fraction analyzed by fast-performance liquid chromatography
(FPLC) of fasting plasma for normal non-BMT transplanted
(LPL
+/+), LPL
-/-RLPL
-/- and LPL
+/+RLPL
-/- mice at 20 weeks
after BMT. Consistent with the results of plasma lipid level
measurements, LPL
+/+RLPL
-/- mice showed a marked reduction
of TG and Chol. content distributed in CM/VLDL fractions and
a moderate increased HDL-C concentrations. In light of the
crucial roles of apoA1 and ABCA1 in the formation of mature
HDL particles, then the expression levels of those genes in liver
tissues were examined. As shown in figure 2C, no significant
changes at expression levels were observed between the two BMT
groups, whereas their levels were significantly lower than those of
wild-type mice (p,0.05).
Subsequently, an oral fat tolerance test was used to assess the
catabolism of both enterogenous and liver-derived TRLs. Figure 3
shows that plasma TG levels peaked during 2 h and 12 h in LPL
+/+
Figure 1. Effects of hematopoietic cell-derived LPL on plasma
lipid levels. All mice were fasted overnight and plasma at 0, 4, 8 and
16 weeks after BMT was collected. Plasma TG levels (A), TC levels (B) and
HDL-C levels (C) were measured as described in methods sections.
Values were expressed as means 6 SEM. * p,0.05, ** p,0.01 for
LPL
+/+RLPL
-/- group compared to LPL
-/- RLPL
-/- group.
doi:10.1371/journal.pone.0025620.g001
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+/+RLPL
-/- mice, with peak values of TG at
270680.4 mg/dl and 6.661.1610
3 mg/dl, respectively. However,
plasma TG levels in LPL
-/-RLPL
-/- mice was increased constantly
from initial levels around 1.6610
3 mg/dl to near 14610
3 mg/dl
without discernable peak during a 24 h observing period, with
higher TG levels than those in LPL
+/+RLPL
-/- mice at time points
of 12 h (p,0.05) and 24 h (p,0.01). Thus, the clearance of plasma
exogenous TG, mainly carried in CMs was accelerated in
LPL
+/+RLPL
-/- mice, although it is still much slower than that in
LPL
+/+ mice.
LPL activity and LPL expression
To determine whether the reduced plasma TG levels and
accelerated fat clearance was due to the effect of hematopoietic
cell-derived LPL in LPL
+/+RLPL
-/- mice, LPL activity and LPL
mRNA levels were compared among three groups. As shown
in figure 4A, fasted post-heparin plasma LPL activities in
LPL
+/+RLPL
-/- mice increased by 12-fold (71.767.8 vs.
5.563.7 mU/ml, p,0.01) compared with LPL
-/-RLPL
-/- mice,
which were still significantly lower than that in wild-type mice
(14069.6 mU/ml, p,0.01). Substantial LPL activity and expres-
sion were predominantly found in macrophage-enriched organs
such as the liver, spleen and lung in LPL
+/+RLPL
-/- mice whereas
similar LPL activity and expression was absent in LPL
-/-RLPL
-/-
mice. However, LPL activity and expression in tissues were
significantly lower in LPL
+/+RLPL
-/- mice than those of wild-type
mice (figure 4B and 4C). In addition, no human Ad-LPLS447X
gene expression was found in any groups of mice (data not shown).
Similar to macrophage, LPL protein in LPL
+/+ and LPL
+/+
RLPL
-/- mice was stained positively and localized close to
trabecular veins and sinusoidal space in tissue sections of the liver,
whereas no LPL positive staining was found in LPL
-/-RLPL
-/-
mice (figure 5).
Histological and Lipid Analysis in Liver
As shown in figure 6A, LPL
-/-RLPL
-/-mice exhibited normal
liver architecture but less intracellular lipid vacuoles, compared
with LPL
+/+ and LPL
+/+RLPL
-/- mice. Liver TG levels in LPL
+/+
RLPL
-/- mice were increased by 47.8% when compared with that
in LPL
-/-RLPL
-/-mice (6.86 0.7 vs. 4.660.5 mg/g wet tissue,
p,0.05), identical to that in LPL
+/+ mice (7.260.4 mg/g wet
tissue, p.0.05) (figure 6B). No significant changes were observed
in the expression levels of those genes related to hepatic lipid
metabolism between the two BMT groups, which were markedly
lower than those of wild-type mice (p,0.01) (figure 6C).
Discussion
In this study, through transplantation of wild-type hematopoi-
etic stem cells, LPL activity and mRNA were noticeably detected
Figure 2. Plasma lipoprotein particle characterized by FPLC
and hepatic gene expression involved in HDL synthesis.
Lipoprotein profiles were determined by FPLC followed by TG (A) and
cholesterol (B) analysis of each fraction. C: The expression levels of
apoA1 and ABCA1 were determined by the RT-PCR methods.
# p,0.05,
*p ,0.05, for LPL
+/+RLPL
-/- and LPL
-/- RLPL
-/- mice vs. LPL
+/+ mice,
respectively (n=6 for each group).
doi:10.1371/journal.pone.0025620.g002
Figure 3. Effects of hematopoietic cell-derived LPL on clear-
ance of intragastric fat load. Each group mice were received an oral
fat load test and plasma TG levels were determined at the respective
time points. Values were expressed as means 6 SEM. * p,0.05,
** p,0.01, for LPL
+/+RLPL
-/- mice compared to LPL
-/- R LPL
-/- group,
respectively.
doi:10.1371/journal.pone.0025620.g003
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described earlier. B: LPL activity of various tissues was measured. C: LPL gene expression in various tissues and cells was determined by RT-PCR (left
panel) or Quantitative Real-Time PCR (right panel) method. Columns and bars represent means6SEM. * p,0.05, ** p,0.01, for LPL
+/+RLPL
-/- mice vs.
LPL
-/- R LPL
-/- mice;
# p,0.05,
##p,0.01, for LPL
+/+RLPL
-/- mice vs. LPL
+/+ mice (n=6 for each group).
doi:10.1371/journal.pone.0025620.g004
Figure 5. Immunocytochemical detection of macrophage and LPL staining in wild-type, LPL
-/- mice transplanted with bone marrow
from wild-type or LPL
-/- mice, appeared in brown. Representative images show macrophages (upper panel) and LPL protein (lower panel) stain
in paraffin sections of liver. Bars represent 20 mm.
doi:10.1371/journal.pone.0025620.g005
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-/- mice, indicating that
LPL
-/- chimeric mice expressing LPL exclusively in hematopoietic
cell were successfully generated through BMT. Given that
macrophages are the only leukocytes that express LPL, LPL
+/+
RLPL
-/- mice would undoubtly serve as an alternative model to
study the role of macrophage-derived LPL in lipoprotein
metabolism.
Our results clearly showed for the first time that hematopoietic
cell-derived LPL alone was nearly sufficient to compensate for the
lack of LPL in other tissues with regard to improving
Figure 6. Effects of hematopoietic cell-derived LPL on hepatic histology and lipid content. A: Images show Oil Red O (upper panel) and
Hematoxylin-eosin stain (lower panel) in cryocut sections of liver. Bars represent 20 mm. B: Total lipids were extracted from livers of mice. TG and TC
contents in each group were determined as described above. C: Messenger RNA levels of hepatic lipid metabolism involved gene. Columns and bars
represent means6SEM.
# p,0.05, for LPL
+/+RLPL
-/- mice vs. LPL
+/+ mice; * p,0.05, for LPL
+/+RLPL
-/- mice vs. LPL
-/- R LPL
-/- mice (n=6 for each
group).
doi:10.1371/journal.pone.0025620.g006
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+/+RLPL
-/-
mice were observed up to 12-fold increase of plasma LPL catalytic
activity, a significant increase in plasma HDL-C and rapid
declines of TG and TC levels, characterized by drastically
decreased TG and Chol. content in the VLDL/CM lipoprotein
fractions. These findings are in contrast to previous studies using
mice with normal LPL function as recipients in BMT experiments,
in which macrophage LPL exerted no or mild effects on plasma
lipid levels[8,9,10]. However, in a study on the functional role of
cardiac LPL, Levak-Frank et al demonstrated the importance of
choosing proper animal models in assessing the contribution of
LPL from various tissues to lipoprotein metabolism [3]. While
heart-specific LPL expression in wild-type mice only reduced
plasma TG to 50% of normal controls, the similar expression of
LPL in homozygous LPL deficient mice rescued the neonatal
lethality and completely prevented the extreme HTG phenotype
which could have occurred in LPL deficient mice if these animals
had survived to adulthood. As a result, the effect of LPL derived
from bone marrow was made discernable in a LPL-deficient
background, which otherwise would be masked by high levels of
LPL present in adipose tissue and skeletal muscle. In fact, our
findings extended the observations made earlier by Hussain et al
who found that guinea pigs, dogs and rats did not exhibit
significant uptake of exogenous CMs by bone marrow whereas
rabbit and a New World primate accumulated 1/2 and 1/10 of
injected CMs in bone marrow, respectively[19,20]. The current
results implies that hematopoietic cell-derived LPL rather than
bone marrow in mice may participate actively in CM metabolism
and promote the removal of plasma TGs carried in CMs in
normal conditions.
Despite markedly reduced plasma TG levels by introduction of
LPL via BMT, the acute plasma fat clearance rate in LPL
+/+
RLPL
-/- mice was still significantly slower than that in wild-type
mice, indicating that hematopoietic cell-derived LPL activity alone
is nevertheless inadequate for complete correction of severely
impaired fat tolerance in LPL
-/- mice.. Regarding this, it appears
to serve as a secondary determinant of plasma TG hydrolysis
unlike muscle and adipose tissue-derived LPL.
In addition to rapidly reduced TG levels, plasma HDL-C levels
were also increased by 1.7-fold in LPL
+/+RLPL
-/- mice during the
same duration. Our results provided strong evidence that
hematopoietic cell-derived LPL could accelerate the clearance of
plasma atherogenic lipoproteins such as CM/VLDL remnant in
the HTG state, and lead to the generation of anti-atherogenic
lipoproteins, HDLs. However, we did not find the up-regulation of
apoA1 and ABCA1 expression in the liver, the 2 of the major
factors involved in HDL biogenesis. In fact, it is known that HDL
can also be generated via enzymatic action of LPL, ie, lipolysis of
TRLs [21]. In this process, HDL will be formed mainly through
the transfer of surface components from TG-rich lipoproteins, ie,
phospholipids and apoproteins like apoAI, apoCs. Therefore,
when LPL activity is increased HDL could be generated without
up-regulation of apoAI and ABCA1 gene expression. In the
present study it is conceivable that lipolysis of TRLs mediated by
LPL derived from hematopoietic cell in LPL
-/- mice contributes
directly to the generation and maturation of HDL particles
through direct transfer of surface components from TG-rich
lipoprotein catabolism. To this end, our findings are in good
agreement with earlier study by Strauss GJ et al, who reported that
LPL, together with apoA1 and ABCA1, was crucial in the
formation of mature HDL particles [22]. However, direct evidence
may be obtained in further studies by generating ABCA1/LPL or
apoA1/LPL double-knockout mice.
It is also noticeable in current study that introduction of LPL-
producing hematopoietic cells to LPL
+/+RLPL
-/- mice resulted in
an increased liver TG content as well, similar to the levels found in
normal mice. This could be related to the enhanced expression of
LPL in the liver after BMT. Catalytically active LPL in the liver
will certainly increase the local generation of free fatty acids via
hydrolysis of TG carried in CM/VLDL in the hepatic circulation,
combined with pre-existing FFA pool as demonstrated by Teusink
B et al [23]. Influx of free fatty acids into hepatocytes will results in
TG synthesis for storage or VLDL package/secretion. However,
no significant change of the hepatic genes involved in TG synthesis
and VLDL package/secretion could be observed between the
mice receiving either LPL
+/+ or LPL
-/- hematopoietic cells.
Therefore, the major source to accumulated hepatic TG in
LPL
+/+RLPL
-/- mice could be from direct uptake of remnant
TG-rich lipoproteins during their catabolism processing by LPL in
the liver because these remnant lipoproteins will easily pass
through the liver fenestrae and become accessible to receptors for
remnant uptake. This notion has received support from a study
which demonstrated that liver-specific LPL transgenic expression
in LPL knockout mice led to excessive amounts of intracellular
lipid droplets in the liver [24].
In a previous study[13],we reported the occurrence of
spontaneous atherosclerosis in LPL deficient HTG mice older
than 15 months,which was further confirmed by a recent report on
atherogenicity in Gpihbp1-deficient HTG mice[18]. In light of the
proatherosclerosis role of macrophage LPL, this raises an issue of
whether or not macrophage LPL expressing under the hypertri-
glyceridemia state further increases the susceptibility of athero-
sclerosis in LPL
-/- mice. Surprisingly, no obvious atherosclerotic
plaques were observed in both BMT and wild-type mice in our
current study (data not shown). Considering the limited life
expectancy of LPL deficient mice undergoing BMT, it would be
difficult to perform atherogenic studies in these mice. It might be
helpful to generate LPL and apoE double-knockout mice with
combined severe hypercholesterolemia and hypertriglyceridemia
in further determining the correlation between the more favorable
lipoprotein profile resulting from LPL expression in hematopoietic
cell and risk of atherosclerosis in vivo.
In conclusion, our results show that hematopoietic cell-derived
LPL could ameliorate severe hypertriglyceridemia and hypo-
alpha-cholesterolemia, as well as normalize hepatic lipid content
even when LPL is absent in muscle and adipose tissue in LPL
-/-
mice. This study should shed light on the special role that LPL
derived from hematopoietic cells in lipoprotein metabolism and
atherosclerosis.
Materials and Methods
Animals
LPL-deficient mice were rescued from neonatal death by
intramuscular injection of a recombinant adenovirus coding for
human LPL beneficial mutant, Ad-LPLS447X, as previously
described [12,13]. Genotyping was done using genomic DNA
extractedfrom tails byPCRandwasdesignated LPL
-/-andLPL
+/+
accordingly.
All mice used for BMT experiments were maintained in
microisolator cages with sterilized regular chow and had free
access to autoclaved acidified water (100 mg/L neomycin and
10 mg/L polymyxin B sulfate). All procedures were performed in
accordance with the "Principles of Laboratory Animal Care" and
approved by the Animal Care Committee, Peking University
Health Science Center (No.La2010-061).
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Female LPL
-/- C57BL/6 mice (aged 6 to 8 weeks) were
subjected to 900 rads lethally total body irradiation by using a
cesium gamma source. Bone marrow cells used for repopulation
were extracted from the femur and tibia of male LPL
-/- C57BL/6
mice and male LPL
+/+ C57BL/6 mice (aged 6 weeks). Four hours
later, 5610
6 bone marrow cells in 300 ml of RPMI-1640 media
from either male LPL
-/- or male LPL
+/+ mice were injected into
the tail vein of all irradiated mice. Age-matched female LPL
+/+
littermates that did not undergo BMT served as control group.
All mice were sacrificed and blood samples were collected for
FPLC or LPL activity assay at the end of the twentieth week after
BMT, followed by the removal of liver, spleen, lung, heart and
skeletal muscle. The tissues were processed for the measurement of
lipid content, RNA and tissue LPL enzyme activity. Resident
peritoneal macrophages in mice were harvested by washing the
peritoneal cavity with RPMI 1640 after intraperitoneal injection of
2 ml 3% thioglycollate broth 4 days ago[6]. Bone marrow cells
were collected as described above and prepared with macrophages
for RNA extraction.
Lipid Analysis in Plasma and Liver
For lipid analysis, blood samples were collected by retro-orbital
bleeding under anesthesia following an overnight fast for the
determination of TC and TG levels using commercial kits (Sigma,
MO, USA). HDL-C was quantified after precipitation of
apolipoprotein B-containing lipoproteins with an equal volume
of a 20% polyethylene glycol solution, as described previously
[25]. For the analysis of the plasma lipoprotein distribution,
lipoproteins in 200 ml of pooled plasma from 3 mice per group
were isolated by FPLC using a Superose 6 column (Amersham
Bioscience Inc., USA) as described [10]. Thirty five fractions of
0.5 ml each were collected and enzymatically assayed for Chol.
and TG content.
Fat Tolerance Test
Mice were fasted overnight. After taking a basal blood sample
by retro-orbital bleeding at t=0, animals received an intragastric
load of 200 ml olive oil gavage. Additional blood samples were
drawn 1, 2, 3, 4, 8, 12 and 24 h after olive oil administration.
Plasma TG levels were measured as described above.
Determination of LPL Enzyme Activity
To determine plasma LPL activity, post-heparin plasma was
obtained as described above and LPL activity was determined
using radioactive trioleoylglycerol emulsion substrate according to
an established method[7]. Enzyme activity was expressed as mU/
ml (1 mU corresponds to 1 nM free fatty acid generated per
minute).
For LPL activity of tissues, individual tissues were weighed and
then homogenized in 25 mM ammonia buffer prepared. The
homogenates were centrifuged at 10610
3 g for 20 min at 4uC and
the clear supernatant was used for the assay of LPL activity. Tissue
LPL enzyme activity was expressed as mU/ml.g wet tissue.
RNA Isolation and Real-Time PCR
Total RNA from tissues was isolated using Tri Reagent (MRC,
USA) and first-strand cDNA was generated by using a RT kit
(Invitrogen, USA). Quantitative Real-Time PCR was performed
using following primer sets: LPL (59-GTGGCCGAGAGCGA-
GAACAT-39,5 9-GC TTTCACTCGGATCCTCTC-39); ACC
(59-CCAGACCCTTTCTTCAGC-39,5 9-TTGTCGTAGTGG-
CCGTTC-39); FAS(59-GCCTCCGTGGACCTTATC-39,5 9-A-
CAGACACCTTCCCGTCA -39); SREBP-1c (59-AACGTCA-
CTTCCAGCTAGAC-39,5 9-CCACTAAGGTGCCTACAGAG
C-39); SCD-1 (59-CGTCAGCACCTTCTTGAGATAC-39,5 9-
TCACTGGCAGAGTAGTCG TAGG-39); ACO (59-GGTGG-
GTGGTATGGTGTCGTAC-39,5 9-CAAAGACCTTAACGGT
CACGTAGTG-39); DGAT-1 (59-ATCTGAGGTGCCATCG-
TC-39,5 9-ATGCCATACTTGATA AGGTTCT-39); CPT-1
(59-CGCACGGAAGGAAAATGG-39,5 9-TGTGCCCAATAT-
TCCTG G-39); MTP (59-GGAAAGCAGAGCGGAGAC-39,5 9-
AGAGCAAGGGTCAGGCAC-39); apoA1 (59-GAGGAGCAA-
GGTATCGG-39,5 9-GGGAAACAGCCCAGTC-39); ABCA1
(59- CGTTTCCGGGAAGTGTCCTA-39,5 9-GCTAGAGAT-
GACAAGGAGGATGGA-39) and 18 s (59-GGAAGTGCAC-
CACCAGGAGT-39,5 9-TGCAGCCCCGGACATCTAAG-39).
Amplifi- cations were performed in 35 cycles using an opticon
continuous fluorescence detection system (MJ Research) with
SYBR green fluorescence (Molecular Probes, Eugene, USA). All
samples were quantitated for relative quantitation of gene
expression by using 18 s ribosomal RNA as an internal standard,
then normalized to wild-type.
Immunohistochemistry
To detection of LPL in liver and heart, liver samples fixed in 4%
buffered formalin were embedded in paraffin. Seven-mm-thick
sections immersed in 0.01M PBS (PH7.4), and then incubated
overnight at 4uC with anti-LPL mAb AM4(recognizes both human
and mouse LPL)at 1:100 dilution after treatment with blocking
reagents (Histomouse Kit, ZyMed Co) [26]. The sections were
treated with goat HRP-labeled antibodies (Zhongshan Bio Co,
China) to mouse IgG at 1:200 dilution for 45 minutes at 37uC. A
SABC kit and DAB substrate were then used to yield a brown
reaction product. Slides were counterstained with hematoxylin,
mounted with glycerol gelatin (Sigma, MO, USA) and examined
with a light microscope.
For the localization of mouse macrophages, a monoclonal rat
anti-Mac-3 antibody (BD Pharmingen) was used for the staining of
Mac-3 as previously described [13].
Histological and Lipid Analysis in Liver
For lipid staining, segments of hepatic tissues were embedded in
OCT and snap-frozen in liquid nitrogen. Seven-mm-thick cryocut
sections were stained with Oil red-O (ORO) or hematoxylin-eosin
staining. Lipids of liver tissues were measured by a modification of
the method described before [27]. Total lipid were evaporated
under nitrogen to dryness and redissolved in 0.5 ml 3% triton X-
100 to determine TG and TC.
Statistical Analysis
Quantitative data were given as means 6 SEM. Statistical
significance was tested using two-tailed Student’s t test and one-
way ANOVA (Newman – Keuls test) by the computer program
Prism (GraphPad Software). Differences were considered signifi-
cant at p,0.05.
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